← Back to Clinical Trials
Recruiting NCT06373822
New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
Trial Parameters
Condition Adenomyosis
Sponsor Université Catholique de Louvain
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2024-03-21
Completion 2031-09
Interventions
Circulating-mirna
Brief Summary
Objectives: To identify differentially expressed miRNAs in the blood of adenomyosis patients in view to develop new diagnostic methods Hypotheses Circulating miRNAs may be abnormally expressed in patients suffering from adenomyosis and could be used to diagnose the disease Study Design Blood samples will be collected from healthy subjects and adenomyosis patients and miRNAs will be isolated and analyzed to detect potential differences.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Pre-menopausal Exclusion Criteria: * HIV or Hepatitis-positive * having participated in another clinical study in the 12 months prior to recruitment * presenting symptoms of endometriosis
Related Trials
NCT06864494
Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometr
View Trial →
NCT06373822
New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
View Trial →
NCT06991595
Fertility Limiting Diseases of Pelvic Organs and Their Influence on Receptivity of Endometrial Cavit
View Trial →